Angiography News and Research

RSS

Debate on rationality of coronary angiography in low risk patients continues

A new study reveals that American hospitals vary widely in how they decide who's eligible for an invasive type of heart scan.

9 Aug 2011

FDA clears Toshiba's patient-friendly 3T MR system

In the 3T MR marketplace, patient compliance often impacts image quality and patient throughput. As the only 3T MR system designed to improve patient compliance and comfort while offering advanced radiology capabilities, Toshiba America Medical Systems, Inc.'s new Vantage TitanTM 3T open bore MR has received FDA clearance.

8 Aug 2011

Study: Low lifetime recreational activity may increase prevalence of PAD

New research published in the August 2011 issue of the Journal of Vascular Surgery, the official publication of the Society for Vascular Surgery, indicates that there may be a connection between low lifetime recreational activity (LRA) and increased peripheral arterial disease.

5 Aug 2011

Abiomed first quarter fiscal 2012 revenue up 25% to $27.4 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2012 revenue of $27.4 million, up 25% compared to revenue of $22.0 million in the same period of fiscal 2011.

4 Aug 2011

Methods for radiation dose optimization in head CT scans

An article in the August issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in head computed tomography (CT) scans. Head CT is the second most commonly performed CT examination, with 28 percent of the total number of CT examinations.

1 Aug 2011

GE Healthcare introduces Veo CT image reconstruction technology in Canada

GE Healthcare announced the introduction of a breakthrough Computed Tomography (CT) image reconstruction technology, called Veo, in Canada. The industry's first Model-based Iterative Reconstruction (MBIR) technique, Veo is designed to help physicians deliver accurate diagnoses by enabling high CT image quality at significantly lower dose.

25 Jul 2011

AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome

AstraZeneca announced today that the US Food and Drug Administration (FDA) has approved BRILINTA (ticagrelor) tablets to reduce the rate of heart attack and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS), compared to clopidogrel.

21 Jul 2011

New report: Global cardiac catheters market to reach US$2.1B by 2015

The global cardiac catheters market is forecast to reach US$2.1 billion by 2015 at a CAGR of 12.9% during the analysis period 2009-2015, according to a new report available on companiesandmarkets.com.

20 Jul 2011

Coronary CTA non-invasive and safe for children

Coronary computed tomography angiography (CTA) has excellent image quality and diagnostic confidence for the entire spectrum of pediatric patients, with significant reduction of risk with recent technological advancements, according to a study to be presented at the Sixth Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT) in Denver, July 14-17.

18 Jul 2011

Rcadia reports promising results from calcium scoring cCTA trial

Rcadia Medical Imaging has achieved proof-of-concept with the first fully automated software that performs calcium scoring directly from a coronary CT angiography (cCTA) study.

15 Jul 2011

Coronary artery disease is a predictor for new-onset atrial fibrillation after heart attack

Results from a case control study show that coronary artery disease affecting the atrial branches is an independent predictor for new-onset atrial fibrillation (AF) after acute myocardial infarction (MI), or heart attack.

12 Jul 2011

ThromboView gets positive results in study evaluating accuracy and safety

Drug and diagnostic company Agenix Limited (ASX: AGX), today announced the positive results of a study to evaluate the efficacy and accuracy

7 Jul 2011

New data compares gender effect on survival after abdominal aortic aneurysm repair

New data in the July 2011 issue of the Journal of Vascular Surgery, the official publication of the Society for Vascular Surgery, compares the effects of gender on long-term survival in different types of abdominal aortic aneurysm (AAA) repair.

7 Jul 2011

Lantheus commences flurpiridaz F 18 PET MPI Phase 3 trial for detection of coronary artery disease

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of the first of two Phase 3 clinical trials to assess myocardial perfusion using Positron Emission Tomography (PET) imaging with flurpiridaz F 18 in patients with suspected or known coronary artery disease (CAD).

1 Jul 2011

Coronary CT angiography may effectively screen for heart disease in African-Americans

Researchers may have discovered one reason that African Americans are at increased risk for heart attacks and other cardiovascular events.

28 Jun 2011

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

23 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).

22 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

22 Jun 2011

ESC publishes position paper to raise the profile of vulnerable plaques

The European Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular Biology has published a position paper to raise the profile of vulnerable plaques and the need for greater use of therapies to promote plaque stabilisation.

15 Jun 2011

CorMedix completes enrollment in CRMD001 Phase II trial for treatment of acute kidney injury

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, announced it successfully completed patient enrollment in its phase II Contrast-Induced Acute Kidney Injury study with its oral drug candidate CRMD001.

14 Jun 2011

Angiography News and Research

Debate on rationality of coronary angiography in low risk patients continues

FDA clears Toshiba's patient-friendly 3T MR system

Study: Low lifetime recreational activity may increase prevalence of PAD

Abiomed first quarter fiscal 2012 revenue up 25% to $27.4 million

Methods for radiation dose optimization in head CT scans

GE Healthcare introduces Veo CT image reconstruction technology in Canada

AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome

New report: Global cardiac catheters market to reach US$2.1B by 2015

Coronary CTA non-invasive and safe for children

Rcadia reports promising results from calcium scoring cCTA trial

Coronary artery disease is a predictor for new-onset atrial fibrillation after heart attack

ThromboView gets positive results in study evaluating accuracy and safety

New data compares gender effect on survival after abdominal aortic aneurysm repair

Lantheus commences flurpiridaz F 18 PET MPI Phase 3 trial for detection of coronary artery disease

Coronary CT angiography may effectively screen for heart disease in African-Americans

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

ESC publishes position paper to raise the profile of vulnerable plaques

CorMedix completes enrollment in CRMD001 Phase II trial for treatment of acute kidney injury

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News